408 related articles for article (PubMed ID: 7906567)
1. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
Tomita Y; Sachs DH; Sykes M
Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
[TBL] [Abstract][Full Text] [Related]
2. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313
[TBL] [Abstract][Full Text] [Related]
3. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
4. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
5. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
[TBL] [Abstract][Full Text] [Related]
6. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation.
Down JD; Tarbell NJ; Thames HD; Mauch PM
Blood; 1991 Feb; 77(3):661-9. PubMed ID: 1991176
[TBL] [Abstract][Full Text] [Related]
7. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
Hayashi H; LeGuern C; Sachs DH; Sykes M
Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
[TBL] [Abstract][Full Text] [Related]
8. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
9. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
10. Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance.
Sykes M; Sheard MA; Sachs DH
J Exp Med; 1988 Aug; 168(2):661-73. PubMed ID: 3045249
[TBL] [Abstract][Full Text] [Related]
11. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
Shatry AM; Jones M; Levy RB
Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
[TBL] [Abstract][Full Text] [Related]
12. Multiple mixed chimeras: reconstitution of lethally irradiated mice with syngeneic plus allogeneic bone marrow from multiple strains.
Chester CH; Sykes M; Sachs DH
Res Immunol; 1989; 140(5-6):503-16. PubMed ID: 2675227
[TBL] [Abstract][Full Text] [Related]
13. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
14. The recovery of resistance to alloengraftment following lethal irradiation and administration of T cell-depleted syngeneic bone marrow.
Chester CH; Sykes M; Sachs DH
Bone Marrow Transplant; 1989 Mar; 4(2):195-200. PubMed ID: 2650790
[TBL] [Abstract][Full Text] [Related]
15. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
Gaines BA; Colson YL; Kaufman CL; Ildstad S
Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
[TBL] [Abstract][Full Text] [Related]
16. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
17. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery.
Tiberghien P; Longo DL; Wine JW; Alvord WG; Reynolds CW
Blood; 1990 Oct; 76(7):1419-30. PubMed ID: 2207317
[TBL] [Abstract][Full Text] [Related]
18. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
[TBL] [Abstract][Full Text] [Related]
19. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
20. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
